Furthermore, SNPs at APOB rs693 resulting in amino acid substitution and SNPs at rs104203, which result in a silent mutation, have been reported to be associated with dyslipidemia (Tsunoda, Harihara, Tanabe, & Dashnyam, 2012) and an increased risk of breast cancer in Chinese individuals (Liu et al., 2013). This evidence concerns the gene APOB and metabolic syndrome.